Move to menuMove to category menuMove to main contents
Data & Policies

Awards and Initiatives

Global Initiatives and Memberships

SK bioscience’s membership in associations and global initiatives is as follows.

Global Initiatives and MembershipsIt indicates the status of association and global initiative membership.
Status of Participation
Korea Pharmaceutical and Bio-Pharma Manufacturers Association
Korea Biotechnology Industry Organization
Korea Biomedicine Industry Organization
International Vaccine Institute(IVI)
Developing Countries Vaccine Manufactures Network(DCVMN)
TCFD(Task Force on Climate-Related Financial Disclosures)

ESG Rating


KCGS A Grade
2022 KCGS Integrated Evaluation
Environmental A Grade, Social A+ Grade, Governece A Grade
With high transparency and expertise, the Korea Corporate Governance Service (KCGS) has been conducting corporate governance assessments since 2003. In 2011, KCGS began assessing ESG management to evaluate sustainability levels of listed companies in South Korea. Its ESG evaluation model not only conforms to international standards such as OECD Principles of Corporate Governance and ISO26000, but also faithfully reflects the domestic legal system and management environment.


2023 MSCI ESG Ratings
October 2021 B Grade, January 2023 BBB Grade
MSCI(Morgan Stanley Capital International), which has been providing ESG evaluation since 1999, evaluates ten topics and thirty-five core issues by ESG area, and gives evaluation results in seven grades from AAA to CCC. A weight is given to the governance evaluation, and in addition to the overall evaluation rating, a separate rating is given for each ESG area.

Awards and Certifications



In accordance with the guidelines of the Task force on Climate-related Financial Disclosures, SK bioscience discloses the impact of climate change on corporate financials every year.
Participation period: 2022


Obtained COVID-19 vaccine manufacturing and quality certification in 2021-2022
Andong City

Local Government Award

Awarded by Andong City in recognition of social value realization in connection with the region in 2019
Medical Korea

Medical Korea Grand Prize

Received a total of six awards in recognition of vaccine development from 2012 to 2019
ISO 45001

ISO 45001

Acquired ISO 45001, the international standard for L HOUSE safety and health in 2018
ISO 14001

ISO 14001

SK bioscience systematically manages the environmental impact of all company activities, products, and services by introducing a global standard environmental management system. The company complies with requirements to protect the environment in accordance with regulations and procedures. We also check whether our compliance measures are well-implemented and make efforts to realize improvements every year.
Participation period : 17 Nov. 2022
ISO/IEC 27001

ISO/IEC 27001

SK bioscience introduces a global standard information security management system, preemptively manages and protects information and assets, and strives to comply with legal requirements.
K Bio Health

Osong New Drug Award/Minister of Food and Drug Safety Prize

Recognized for the development of the world’s first cell-culture quadrivalent inactivated influenza vaccine, “SKY Cellflu Quadrivalent Prefilled Syringe” in 2016. Received a total of two awards in recognition of its contribution to localization of vaccines in 2018

Gold Rating Certified by LEED in the U.S.

Received the world’s first gold grade given to a pharmaceutical factory from LEED (Leadership in Energy and Environmental Design), an eco-friendly building certification system in the United States in 2013.